After Covid-19, the next big target for vaccine makers is a respiratory virus that kills up to 500 children a year nationwide and has been a leading cause of hospitalizations in the United States for decades.
Respiratory syncytial virus, or RSV, infects almost everyone at some point and causes mild, cold-like symptoms in most people. But it can lead to serious health problems like breathing difficulties and pneumonia in infants and older adults.
https://www.wsj.com/articles/pfizer-moderna-j-j-see-respiratory-virus-rsv-as-next-vaccine-target-11650015001?mod=pls_whats_news_us_business_f Pfizer, Moderna, J&J see respiratory virus RSV as next vaccine target